Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Sacituzumab govitecan Sponsors: National Taiwan University Hospital; Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials